Skip to content

4Accepted May 24, 5:53 PM ET

Garabedian Christopher Nishan 4

LABPLandos Biopharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:53 PM

May 24, 2023

Filed

May 24, 2023

Documents

1

Size

5.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.